United States: Follow The Yellow Brick Road

The disease known as chronic traumatic encephalopathy (CTE) is detected at autopsy. Using immunohistochemical staining technology, pathologists look for abnormal depositions of hyper-phosphorylated tau protein, a substance that occurs naturally in the body and is responsible for stabilizing nerve cells. If the staining pattern matches certain criteria, a diagnosis is made, such as CTE, Lewy Body disease or Alzheimer's disease. There are many conditions in which the protein tau accumulates in the brain; it even accumulates with aging.

Much work is being done to correlate postmortem CTE pathology with antemortem behavior and neurological function. A correlation could help us understand and alter activity that puts us at risk. Media focus on CTE has brought public awareness to a subject that might otherwise be relegated to the world of medical literature. Frequently in the spotlight, Dr. Ann McKee and her colleagues at Boston University (BU) should be commended for their work in collecting brains and studying tissue samples, which has potentially large implications. However, the matter is far from settled in the scientific community.

Background

Dr. McKee and a host of her colleagues published a report, "Clinicopathological Evaluation of Chronic Traumatic Encephalopathy in Players of American Football," in the Journal of the American Medical Association (JAMA), which was featured in the New York Times piece, "110 out of 111 NFL Brains." The article paints the picture that any pro football player stands a near certainty of neurological impairment based on CTE. In "0.44% of NFL Brains" Wilson Elser addressed the New York Times coverage and pointed out the study's limitations.

BU's 2018 follow-up about "subconcussive" contact got similar media coverage and became the centerpiece of efforts to outlaw organized youth contact sports in a number of states. Pushback from the larger medical community, "limiting head impacts among youth is smart, overstating scientific consensus is not," and grassroots efforts led by parents, volunteers and youth-serving organizations have at least temporarily halted those legislative efforts. In " The Freedom to Swim" Wilson Elser addressed this study's limitations, in particular the prevalence of CTE among the general population. We also noted the potential consequence of kids playing unorganized football without the benefit of proper equipment, adult supervision and concussion protocols, and that the sport the very object of which is to deliver a concussion (boxing) doesn't get the same attention as football.

BU's latest effort, the age of first exposure (AFE) study, concludes that kids who play tackle football and continue through college or beyond have "earlier neurobehavioral symptom onset," and that youth exposure to tackle football "may reduce resiliency to late-life neuropathology." The AFE study looks like a repackaged version of BU's 2015 piece, which drew conclusions about AFE and later-life cognition in former NFL players. Both studies draw from the same pool of data at the BU Brain Bank. One looked only at subjects reported to have played youth football, while another used the larger universe of BU's football player subjects (high school, college, professional) without regard to whether they played youth football, the idea being to get a "control" group. Both drew dissent and criticism from the larger medical community.

What does it mean?

The BU reports draw from the same universe of data. None of the BU subjects has been followed or examined by clinicians for these studies. All have been "diagnosed" based on speculative and unreliable next-of-kin reports. None of the BU studies includes a control group; only those who played football at a high level and demonstrated troubling behavior are in the studies. Yet the BU studies correlate exposure to contact sports with life-threatening neurodegenerative disease.

BU's latest correlation between exposure and disease concludes that those who start playing football below age 14 are more likely to have problems as they age. If true, there are three implications: kids shouldn't play football, those who did are destined for infirmity, and BU is saving our kids.

One problem with the AFE study is that it makes no association between AFE and severity of CTE pathology. Similar to cancer, BU uses a scale to grade CTE pathology, from mild (Stage I) to severe (Stage IV). Contrary to the narrative, the AFE data actually shows (1) the mild CTE group had double the contact sport participation of the severe CTE group; (2) the CTE-positive group lived longer than the CTE- negative group (62 versus 42); and (3) average age at death in the mild CTE group was earlier than the severe CTE (III/IV) group (49 versus 68). In other words, the experiment doesn't prove the theory.

Where it began

In 1928, Martland's groundbreaking study of "Punch Drunk" syndrome looked at boxers who developed neurologic and behavioral issues associated with repeated head trauma. The CTE label was first linked to Punch-Drunk syndrome in the 1940s ("Punch-Drunk syndromes: the chronic traumatic encephalopathy of boxers," Critchley M., Neuro-chirurgie; hommage à Clovis Vincent, Maloine, Paris: 1949). Since then scientists have tried to identify its implications. Between 1954 and 1967, postmortem studies covered boxers with dementia and Parkinson's. A 1973 postmortem of 15 boxers with Punch-Drunk syndrome looked at their neuropathology. This work came before the internet and social media. None of it got the attention that today's studies get.

Fast-forward

In 2005, Bennet Omalu, the Nigerian born pathologist played by Will Smith in Concussion, published the first study associating CTE with professional football. Omalu correlated his 2002 finding of amyloid plaque tau deposits in the brain of Pittsburgh Steeler Mike Webster with family reports of cognitive and behavioral problems. Webster died from coronary artery disease 12 years after retirement.

In 2006, Omalu published a study of Pittsburgh Steeler Terry Long, who committed suicide at 45 by drinking antifreeze. His family reported a first suicide attempt after NFL suspension for steroids, a rollover accident that left him unconscious, a diagnosed major depressive syndrome, hyperthyroidism and a thyroidectomy two months before suicide. Unlike Webster, no amyloid plaque was found. Omalu was unable to account for these and other differences between Long and Webster.

As with the BU reports, neither of the Omalu reports follows their subject antemortem, yet they declare a link between neuropathology and sports concussion.

Where We Are

There remains a scientific gap linking head injuries and neuropathological findings of CTE. In 2015, the National Institutes of Health (NIH) held the first consensus workshop to define neuropathological criteria for the diagnosis of CTE. Despite such attempts to define CTE, there is still no consensus. There is a dearth of research to understand and correlate clinical presentation with postmortem pathology. There is no consensus about the causes of CTE. There has been no scientific study clearly demonstrating a definitive cause-and-effect relationship between head trauma, development of psychological and behavioral changes later in life, and neurodegenerative changes identified postmortem as CTE.

A recent study showing that CTE may be detected in a living person by PET scan with a tau protein tracer holds some promise, but even its authors admit more research needs to be done. CTE neuropathology has been found in individuals with no psychological or behavioral issues. The inter vivos finding of tauopathy, a class of neurodegenerative diseases associated with the pathological aggregation of tau protein, consistent with CTE in one symptomatic individual still lacks a causal link between pathology and symptoms.

As pointed out in "0.44% of NFL Brains," the BU studies that retrospectively correlate symptoms with neuropathology cover a select group of athletes known to have sports concussions. Thus, any claim that a percentage of NFL players are at risk for CTE is simply false. The vast majority of NFL players never develop behavioral and cognitive problems attributed to CTE. More than 250,000 men have played in the NFL, and more than 10 million kids have played organized youth football. Rather than focusing on a few select subjects with known outcomes, longitudinal studies look at the bigger picture. True control group studies actually show a prevalence of CTE in the general population equal to or greater than the prevalence among NFL players.

Moving the Ball

The brain is our most important organ and should be protected from unreasonable risk of injury. Media focus and Hollywood depiction based on work from BU and Omalu have helped bring about concussion protocols and better medical management. These are good results.

Aside from a generalized association with disruption of the blood-brain barrier from movement of the brain within the skull, the cause of CTE remains unknown. Until comorbidities such as opioid use and the genetic presence of apolipoprotein-E4 (the major known genetic risk factor for Alzheimer's disease) are accounted for, the notion that sports participation causes the behavioral and neurological problems attributed by some to CTE remains a theory. Until we account for the prevalence of CTE in the general asymptomatic population, it is unreasonable to assume that simply engaging in sport places one at unreasonable risk of injury.

Disclosures and Acknowledgments: Tony Corleto serves as general counsel for Pop Warner football. He defends concussion litigation. In addition to being an attorney, Alia Najjar is a licensed medical doctor. Before entering the legal profession, she studied at the University of Texas Southwestern Medical School and completed two years of a general surgery residency in Houston, Texas, including neurosurgery, cardiovascular surgery, trauma surgery and pediatric surgery.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Topics
 
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions